Trial Profile
Extension study following the phase I/II clinical study of CT-P13 in the patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Nippon Kayaku
- 07 Jun 2016 New trial record